MDS: what treatments are on the horizon?

Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, outlines therapies on the horizon for both high and low-risk myelodysplastic syndromes. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video